News from the FDA/CDC
News from the FDA/CDC
J&J COVID-19 vaccine wins unanimous backing of FDA panel
The Johnson & Johnson vaccine is expected to offer more convenient dosing and be easier to distribute than the two rival products already...
News from the FDA/CDC
Variants spur new FDA guidance on COVID vaccines, tests, drugs
The FDA has already been communicating with individual manufacturers as they assess the variants’ effect on their products.
News from the FDA/CDC
CDC chief lays out attack plan for COVID variants
Public health leaders are ramping up genome sequencing of the SARS-CoV-2 virus and ensuring that sampling is geographically representative.
News from the FDA/CDC
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Completed safety clinical trial shows occurrence of heart-related events and cancer in RA patients taking the Janus kinase inhibitor is higher...
News from the FDA/CDC
CDC panel: No COVID-19 vaccine safety surprises
News
Anaphylaxis cases after COVID-19 vaccine rising but still rare: CDC
News from the FDA/CDC
CDC issues COVID-19 vaccine guidance for underlying conditions
The CDC guidance had specific information for people with ...
News from the FDA/CDC
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.
News from the FDA/CDC
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.
News from the FDA/CDC
Urgent recall for Penumbra JET 7 Xtra Flex reperfusion catheters
Recall cites a risk for “unexpected death or serious injury” during use for clot removal in stroke patients.
News
FDA safety alert: Face masks with metal can burn during MRI